Under the activation of WNT/β-catenin signaling, activating transcription factor 3 (ATF3)-mediated CCL4 downregulation is considered to reduce the migration of CD103+ dendritic cells into the tumor and reduce CD8+ TILs in melanoma. This evidence concerns the gene ITGAE and melanoma.